Lilly Launches Glucagon Mobile App


By: Mari Gold

Lilly Diabetes recently launched the free Lilly Glucagon Mobile App to educate those who support people living with type 1 diabetes. The interactive app, available on the iTunes store for iPhone and iPad devices, provides caregivers, diabetes educators, and school nurses with visual and audio emergency instructions, as well as tools to track locations of glucagon kits and alerts for expiration dates.

People with type 1 diabetes who experience severe hypoglycemia (low blood sugar) during insulin treatment may require glucagon, a hormone produced in the pancreas to raise blood sugar levels. However, glucagon should not be used by patients who have pheochromocytoma, a rare, usually benign, tumor that develops in an adrenal gland, or those who are allergic to the drug. Diabetes patients should ensure that their relatives and close friends know that if they become unconscious, immediate medical help must be sought.

For more information, go to



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.